Donor-derived interferon γ is required for inhibition of acute graft- versus-host disease by interleukin 12

Journal of Clinical Investigation

Volumn 102, Issue 12, 1998, Pages 2126-2135

  Yang, Yong Guang ^a   Dey, Bimalangshu R ^a   Sergio, Justin J ^a   Pearson, Denise A ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; Cytokine; Lethal irradiation; Mice; T cell activation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032535087     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4992     Document Type: Article

References (16)

1. Manetti, R., P. Parronchi, M.G. Giudizi, M.-P. Piccini, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199-1204.
2. Seder, R.A., R. Gazzinelli, A. Sher, and W.E. Paul. 1993. Interleukin-12 acts directly on CD4+ T cells to enhance priming for interferon-gamma production and diminishes interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
3. Abbas, A.K., K.M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nat. 383:787-793.
4. Magram, J., S.E. Connaughton, R.R. Warrier, D.M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D.A. Faherty, and M.K. Gately. 1996. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity. 4:471-481.
5. Via, C.S., V. Rus, M.K. Gately, and F.D. Finkelman. 1994. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immnnol. 153: 4040-4047.
6. Williamson, E., P. Garside, J.A. Bradley, and A.M. Mowat. 1996. IL-12 is a central mediator of acute graft-versus-host disease in mice. J. Immunol. 157: 689-699.
7. Williamson, E., P. Garside, J.A. Bradley, I.A.R. More, and A.M. Mowat. 1997. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes the cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. J. Immunol. 159:1208-1215.
8. Sykes, M., G.L. Szot, P.L. Nguyen, and D.A. Pearson. 1995. Interleukin-12 inhibits murine graft-vs-host disease. Blood. 86:2429-2438.
9. Yang, Y.-G., J.J. Sergio, D.A. Pearson, G.L. Szot, A. Shimizu, and M. Sykes. 1997. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CDS T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood. 90:4651-4660.
10. Yang, Y.-G., B. Dey, J.J. Sergio, and M. Sykes. 1997. IL-12 prevents severe acute GVHD and GVHD-associated immune dysfunction in a full MHC haplotype-mismatched murine bone marrow transplantation model. Transplantation. 64:1343-1352.
11. Dey, B., Y.-G. Yang, G.L. Szot, D.A. Pearson, and M. Sykes. 1998. IL-12 inhibits GVHD through a Fas-mediated mechanism associated with alterations in donor T cell activation and expansion. Blood. 91:3315-3322.
12. Nastala, C.L., H.D. Edington, T.G. McKinney, H. Tahara, M.A. Nalesnik, MJ. Brunda, M.K. Getely, S.F. Wolf, R.D. Schreiber, W.J. Storkus, and M.T. Lotze. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153:1697-1706.
13. Brunda, M.J., L. Luistro, J.A. Hendrzak, M. Fountoulakis, G. Garotta, and M.K. Gately. 1995. Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J. Immunother. 17:71-77.
14. Schijns, V.E.C.J., B.L. Haagmans, and M.C. Horzinek. 1995. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor-deficient mice. J. Immunol. 155:2525-2532.
15. Wenner, CA., M.L. Guler, S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1996. Roles of IFN-γ and TNF-α in IL-12-induced T helper cell-l development. J. Immunol. 156:1442-1447.
16. Szebeni, J., M.-G. Wang, D.A. Pearson, G.L. Szot, and M. Sykes. 1994. IL-2 inhibits early increases in serum gamma Interferon levels associated with graft-versus-host disease. Transplantation. 58:1385-1393.